Facility Visit

RNS Number:8618E
Bespak PLC
20 June 2006


            Bespak hosts visit for major investors and sector analysts

Bespak plc ("Bespak"), a leader in the design and manufacture of medical devices
for inhaled drug delivery and anaesthesia, is hosting a visit for major
investors and sector analysts to its manufacturing facility in Milton Keynes on
Wednesday 21 June 2006.

The purpose of the visit is to provide investors and analysts with:

   * an overview of Bespak's business strategy;
   * an opportunity to meet with senior and operational management from the
     UK and US;
   * a presentation by the new general manager of King Systems, which Bespak
     acquired last December; and
   * a tour of Bespak's manufacturing facility to see the production of the
     new Exubera(R) device.

The Company is in close period prior to the announcement of its preliminary
results on 12 July 2006.


For further information please contact:

Bespak
Mark Throdahl, Chief Executive             Tel: [phone]
Martin Hopcroft, Group Finance Director

Maitland
Brian Hudspith or Liz Morley               Tel: [phone]


Bespak plc is a leader in specialty medical devices, developing delivery systems
for the pharmaceutical industry and disposable airway management products for
critical care settings.

The company develops and manufactures a range of devices including metered dose
inhalers, dry powder devices, actuators, compliance aids, disposable facemasks,
breathing circuits and laryngeal tubes. The group holds the 2005 Frost &
Sullivan Award for Technology Innovation and has facilities in King's Lynn and
Milton Keynes in the UK, in Indianapolis, Indiana and Kent, Ohio, in the US and
in Mumbai, India. Bespak is a public company quoted on the full list of the
London Stock Exchange (LSE: BPK).




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCIIFSARDIIFIR